STAAR Surgical Co Debt Securities, Available-for-sale, Amortized Cost, Noncurrent
STAAR Surgical Co (STAA) had Debt Securities, Available-for-sale, Amortized Cost, Noncurrent of $11.59 million as of 2023-12-29, per its 10-K filed 2025-02-21.
Financial Statements › Notes › Credit Losses › Debt Securities, Available-for-Sale, Amortized Cost
us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent · last filed 2025-02-21
- 2023-12-29: Debt Securities, Available-for-sale, Amortized Cost, Noncurrent $11.59M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost, Noncurrent |
|---|---|
| 2023-12-29 | $11.59M 10-K · filed 2025-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |